Research and Markets (http://www.researchandmarkets.com/research/d465af/inspire_pharmaceut) has announced the addition of the "Inspire Pharmaceuticals, Inc: Premium Company Profile" company profile to their offering.
Introduction
Inspire Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing prescription pharmaceutical products for diseases in the ophthalmic and respiratory/allergy areas. It made its first significant alliance with University of North Carolina in 1995, by in-licensing rights to UTP for the treatment of lung disease.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors. Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Inspire Pharmaceuticalss marketed products include: AzaSite (azithromycin ophthalmic solution), for the treatment of bacterial conjunctivitis; Elestat (epinastine HCl ophthalmic solution), for the treatment of ocular itching; and Restasis (cyclosporine ophthalmic emulsion), for dry eye disease. Inspire Pharmaceuticals derives its revenues only from license, collaboration and other. The company's total revenues increased at a CAGR of 66% during 2002-2006, from $5 million to $37 million. This represents an absolute total growth of +$32 million for total revenues. The company's biggest contributor to sales growth out to 2010 will be revenues from product sales. Revenues from product sales are expected to increase from $7 million in 2007 to $86 million in 2010. These revenues are related to the company's newly marketed product, AzaSite, launched in the US in August 2007.
Reasons to Purchase
Access all the important information and analysis on the company in a single report. Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain. Gain access to company's adjusted five year financial data along with key ratios and market capitalization.
Key Topics Covered:
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
Landmark Products and Services 8
History 9
Company Financials 11
Stock Market Performance 11
P&L 15
Balance Sheet 18
Cash Flow 18
Business Segment Performance 19
Products & Services 20
Marketed Products 20
Pipeline Products 22
AC Forecast Product Sales 26
Competitors and Strategic Business Relationships 28
Key Competitors 28
Key Suppliers 29
Key Clients 30
Shareholding Structure 31
Strategy 32
Company View 32
Corporate Strategy 35
SWOT Analysis 37
Overview 37
Strengths 38
Weaknesses 40
Opportunities 42
Threats 43
Value Chain Analysis 44
Overview 44
Discovery and Product Development 45
Sales 46
Scorecard 47
Overview 47
Scorecard Analysis 48
Key Employees 49
List of Key Employees 49
Key Employee Biographies 50
Financial and Operational Overview 58
Financial and Operational Overview 58
APPENDIX 61
Ask the analyst 61
Our consulting 61
Disclaimer 61
TABLE OF FIGURES
Figure 1: Inspire Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16
Figure 2: Inspire Pharmaceuticals - Key Strategic Revenues, 2006-2010 ($ Mn) 27
TABLE OF TABLES
Table 1: Inspire Pharmaceuticals - Key Facts 6
Table 2: Inspire Pharmaceuticals - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
Table 3: Inspire Pharmaceuticals - Key Events Impacting Share Price Performance 12
Table 4: Inspire Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
Table 5: Inspire Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 17
Table 6: Inspire Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn) 18
Table 7: Inspire Pharmaceuticals - Cash Flow, 2002-2006 ($ Mn) 18
Table 8: Inspire Pharmaceuticals - Revenue Breakdown by Division, 2002-2006 ($ Mn) 19
Table 9: Inspire Pharmaceuticals - Marketed Products 20
Table 10: Inspire Pharmaceuticals - In-house Pipeline Products 22
Table 11: Inspire Pharmaceuticals - Collaboration Products 23
Table 12: Inspire Pharmaceuticals - Forecast Sales, 2006-2010 ($ Mn) 26
Table 13: Inspire Pharmaceuticals - Key Competitors 29
Table 14: Inspire Pharmaceuticals - Key Suppliers 30
Table 15: Inspire Pharmaceuticals - Key Clients 30
Table 16: Inspire Pharmaceuticals - Key Shareholders 31
Table 17: Inspire Pharmaceuticals - SWOT Analysis Summary 37
Table 18: Inspire Pharmaceuticals - Value Chain Analysis 45
Table 19: Inspire Pharmaceuticals - Scorecard 47
Table 20: Inspire Pharmaceuticals - Key Employees 49
Table 21: Inspire Pharmaceuticals - Financial and Operational Overview 59
For more information visit http://www.researchandmarkets.com/research/d465af/inspire_pharmaceut
Source: Datamonitor
Contacts:
Laura Wood
Senior Manager
Fax from
USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
press@researchandmarkets.com
